Abstract
In the central nervous system (CNS), modulation of neuronal activity is brought about by the actions of endogenous “neurotransmitters” that specifically interact with receptor proteins located in the neuronal cell membrane. In the cholinergic system, acetylcholine is the primary neurotransmitter released in the CNS, and appears to alter neuronal excitability by affecting such processes as cGMP production and K+ flux (Heilbronn and Bartfai, 1978). In contrast to the periphery, in which the cholinergic receptor population is divided between nicotinic and muscarinic subclasses, the CNS-associated cholinergic receptor appears to be predominantly of the muscarinic type, although there is evidence that the spinal cord contains substantial amounts of nicotinic receptors (Heilbronn and Bartfai, 1978). Historically, the initial characterization of cholinergic actions was provided by A. S. V. Burgen. Although these early studies, using smooth muscle tissue (Burgen and Spero, 1968; Burgen et al., 1974), provided initial clues about the peripheral muscarinic receptors, since then there have been numerous investigations, especially following the advent of radioligand binding assays, from which have come many novel observations of physiological significance.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Alberts P and Bartfai T (1976) Muscarinic acetylcholine receptor from rat brain. Partial purification and characterization J. Biol Chem. 251, 1543–1547.
Amitai G., Avissar S, Balderman M, and Sokolovsky M (1982) Affinity labeling of muscarinic receptors in rat cerebral cortex with a photo-labile antagonist. Proc. Natl. Acad. Sci USA 79, 243–247.
Aronstam R S., Abood L. G., and Hoss W. (1978a) Influence of sulfhydral reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol. Pharmacol. 14, 575–586.
Aronstam R. S., SchuesslerJr D. C., and Eldefrawi M. E. (1978b) Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci 23, 1377–1382.
Arunlakshana O. and Schild H. O. (1959) Some quantitative uses of drug antagonists Br J Pharmacol 14, 48–58.
Ash A. S. F and Schild H O. (1966) Receptors mediating some actions of histamine. Br J Pharmacol. 27, 427–43.
Baron B. and Abood L. G. (1984) Solubilization and characterization of muscarinic receptors from bovine brain. Life Sci 35, 2407–2414.
Bevan P. (1984) [3H] Oxotremorine-M binding to membranes prepared from rat brain and heart. Evidence for subtypes of muscarinic receptors. Eur J Pharmacol. 101, 101–110.
Birdsall N. J,M., Burgen A. S.V., and Hulme E C (1978) The binding of agonists to brain muscarinic receptors Mol. Pharmacol 14, 723–736.
Birdsall N. J. M, Burgen A S V., Hulme E. C. (1979a) Muscarinic receptors: Biochemical and Binding Studies, in Recent Advances in Receptor Chemistry (Gualtieri F, Giannella M., and Malchiorre C, eds.) Elsevier/North Holland Biomedical, Amsterdam.
Birdsall N. J. M., Burgen A S. V, and Hulme E C. (1979b) A study of the muscarinic receptor by gel electrophoresis. Br. J Pharmacol. 66, 337–342.
Birdsall N. J. M., Burgen A. S V., Hulme E. C., Stockton J. M., and Zigmond M. J. (1983) The effect of McN-A-343 on muscarinic receptors in the cerebral cortex and heart. Br. J. Pharmacol 78, 257–259
Black J. W, Duncan W. A., Durant C. J., Ganellin C. R., and Parsons E. M (1972) Definition and antagonism of histamine H2-receptors. Nature (Lond.) 236, 385–390.
Brown J. H. and Brown-Masters S. (1984) Muscarinic regulation of phosphatidylinositol turnover and cyclic nucleotide metabolism in the heart Fed Proc 43, 2613–2617.
Burgen A. S. V and Spero L (1968) The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of the gumea pig ileum. Br J. Pharmacol 34, 99–115.
Burgen A. S. V., Haley C. R., and Young J. M (1974) Binding of [3H]-propylbenzilylcholine mustard by longitudinal muscle strips from guinea pig small intestine Br. J Pharmacol. 50, 145–151.
Dunlap J. and Brown J H (1983) Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium. Mol. Pharmacol 24, 15–22
Eckelman W. C., Reba R. C., Rzeszotarski W. J., Gibson R. E., Hill T, Holman B. L., Budinger T., Conklin J. J., Eng R., and Gnssom M P. (1984) External imaging of cerebral muscarinic acetylcholine receptors. Science 223, 291–293
Gorissen H, Aerts G., and Laduron P. (1978) Characterization of digitonin-solubilized muscarinic receptor from rat brain. FEBS Lett 96, 64–68.
Goyal R. K. and Rattan S (1978) Neurohumoral, humoral, and drug receptors for the lower esophageal sphincter. Gustroenterology 74, 598–619.
Haga T. (1980) Molecular size of muscarinic acetylcholme receptors of rat brain FEBS Lett 113, 68–72.
Hammer R., Berrie C. P., Birdsall N. J. M., Burgen A S. V., and Hulme E. C. (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature (Lond.) 283, 90–92.
Hammer R and Glachetti A. (1982) Muscarmic receptor subtypes M1 and M2 biochemical and functional characterization. Life Sci. 31, 2991–2998.
Harden T. K., Meeker R. B., and Martin M. W. (1983) Interaction of a radiolabeled agonist with cardiac muscarinic cholinergic receptors J Pharmacol. Exp. Ther. 227, 570–578
Heilbronn E. and Bartfai T. (1978) Muscarinic acetylcholine receptor Prog Neurobiol. 11, 177–188.
Henis Y. I and Sokolovsky M. (1983) Muscarinic antagonists induce different receptor conformations in rat adenohypophysis. Mol. Pharmacol. 24, 357–365.
Herron G S and Schimerlik M. I. (1984) Protein composition of the atria1 muscarirnic acetylcholine receptor partially purified by wheat germ agglutinin affinity chromatography. Arch. Biochem. Biophys. 230,533–542.
Hosey M. M. (1983) Regulation of ligand binding to cardiac muscarinic receptors by ammonium ion and guanine nucleotides. Biochim. Biophys. Acta 757, 119–127.
Hulme E. C., Birdsall N. J. M., Burgen A. S. V., and Mehta P. (1978) The binding of antagonists to brain muscarinic receptors. Mol. Pharmacol 14, 737–750
Hurko H (1978) Specific [3H] quinuclidinyl benzilate binding activity in digrtonin-solubilized preparations from bovine brain. Arch. Biochem. Biophys 190, 434–445
Jarv J., Hedlund B., and Bartfai T. (1980) Kinetic studies on muscarinic antagonist-agonist competition. J. Biol. Chem 255, 2649–2651.
Kloog Y. and Sokolovsky M. (1978) Studies on muscarinic acetylcholine receptors from mouse brain. Characterization of the interaction with antagonists Brain Res. 144, 31–48.
Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J (1951) Protein measurements with the Folin phenol reagent J Biol, Chem 183, 265–275.
Luthin G. R. and Wolfe B B (1984) Comparison of [3H] pirenzepine and [3H] quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain. J. Pharmacol Exp. Ther. 228, 648–655.
McPherson G. A (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 17, 107–113
Munson P. J. and Rodbard D. (1980) LIGAND: A versatile computerized approach for the characterization of ligand-binding systems. Anal Biochem 107, 220–239.
Murphy K. M. and Sastre K (1983) Obligatory role of a Trrs/choline allosteeric site in guanine nucleotide regulation of [3H]-L-QNB binding muscarinic acetylcholine receptors Biochem. Biophys. Res Commun. 113, 280–285
Nonaka R. and Moroji T (1984) Quantitative autoradiography of muscarinic cholinergic receptors in the rat brain. Brain Res. 296, 295–303.
Nukada T., Haga T., and Ichiyama A (1983) Muscarinic receptors in porcine caudate nucleus (II). Mol. Pharmacol. 24, 374–379.
Potter L. J., Flynn D. D., Hanchett H E., Kalmoski D. L, Luber-Narod J., and Mash D C (1984) Independent M1 and M2 receptors: Ligands, autoradiography and functions. Trends in Pharmacol. Sci (Suppl.) 22–31.
Repke H. and Matthies H. (1980) Biochemical characterization of solubilized muscarinic acetylcholine receptors. Brain Res Bull. 5, 703–709.
Roberts, C M. and Konjovic, J (1969) Differences in the chronotropic and inotropic response of the rat atrium to choline esters, cholinesterase inhibiters, and certain blocking agents. J Pharmacol. Expt Therap. 169, 109–119.
Scatchard G. (1949) The attraction of proteins for small molecules and ions. Ann. NY Acad Sci. 51, 660–672
Shirakawa O., Kuno T., and Tanaka C (1983) The glycoprotein nature of solubilized muscarinic acetylcholine receptors from bovine cerebral cortex Biochem Biophys Res. Commun. 115, 814–819.
Sokolovsky M., Gurwitz D., and Galron R (1980) Muscarinic receptor binding in mouse brain Regulation by guanine nucleotides. Biochem Biophys Res Commun. 94, 487–492.
Stiles G. L. and Lefkowitz R. J (1984) Cardiac adrenergic receptors. Ann. Rev Med. 35, 149–164.
Sulakhe P. V., Jagadeesh G., and Braun A. P (1985) Cardiac Autonomic Receptors and Adenylate Cyclase in Health and Science, in Regulation of Heart Function—Basic Concepts and Clinical Applications (Rupp H. ed.), Thieme-Stratton, New York
Trummlitz G, Schmidt G, Wagner H.-U., Luger P (1984) Confirmational analysis of the antiulcer drug pirenzepine Arzneim.Forsch /Drug Res. 34, 849–859.
Venter J. C (1983) Muscarinic cholinergic receptor structure.J Bio1 Chem 258, 4842–4848.
Vickroy T. W., Yamamura H. I, and Roeske W. R (1983) Differential regulation of high affinity agonist binding to muscarinic sites in the rat heart, cerebellum, and cerebral cortex. Biochem. Biophys. Res. Commun. 116, 284–290.
Wamsley J K., Zarbin M. A., Birdsall N J. M., and Kuhar M. J. (1980) Muscarinic cholinergic receptors: Autoradiographic localization of high and low affinity agonist binding sites. Brain Res. 200, 1–12
Wamsley J K., Gehlert D. R., Roeske W. R., Yamamura H. I (1984) Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H](-)QNB and [3H] pirenzepine. Life Sci 34, 1395–1402.
Watson M, Roeske W R., and Yamamura H I. (1982) [3H] pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci. 31,2019–2023.
Watson M., Yamamura H. I., and Roeske W. R. (1983) A unique regulatory profile and regional distribution of [3H] pirenzepine binding in rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes. Life Sci 32, 3001–3011.
Wei J-W. and Sulakhe P. V (1979) Properties of muscarinic cholinergic receptors in rat atrium. Naunyn Schmiedebergs Arch. Pharmacol. 309, 259–269.
Wilfert B., Davidesko D., Timmermans P., and VanZwieten P. A. 1983 Differential role of M1 and M2 receptors in sympathetic ganglia of the pithed normotensive rat in alpha-adrenoceptor mediated vasoconstriction. J Pharmacol. Exp. Ther. 226, 855–860.
Yamamura H. I. and Snyder S. H. (1974) Muscarinic cholinergic binding in rat brain. Proc Natl Acad. Sci. USA 71, 1725–1729.
Author information
Authors and Affiliations
Editor information
Rights and permissions
Copyright information
© 1986 The Humana Press Inc.
About this protocol
Cite this protocol
Braun, A.P., Sulakhe, P.V. (1986). Muscarinic Cholinergic Receptors. In: Boulton, A.A., Baker, G.B., Hrdina, P.D. (eds) Receptor Binding. Neuromethods, vol 4. Humana Press. https://doi.org/10.1385/0-89603-078-4:139
Download citation
DOI: https://doi.org/10.1385/0-89603-078-4:139
Publisher Name: Humana Press
Print ISBN: 978-0-89603-078-7
Online ISBN: 978-1-59259-609-6
eBook Packages: Springer Protocols